Regression of an abdominal aortic aneurysm after endograft exclusion  by White, Rodney A. et al.
CASE REPORTS 
Regression of an abdominal aortic 
aneurysm after endograft exclusion 
Rodney  A. White,  MD,  Carlos E. Donayre ,  MD,  I rw in  Walot ,  MD,  
George E. Kopchok ,  BS, Er ic P. Wi lson, MD,  and Chr ist ian deVirgi l io, MD,  
Torrance, Calif. 
We describe the regression of  a 6.5 cm diameter abdominal aortic aneurysm in a 
71-year-old patient within I year of  aortic endograft placement. The aneurysm decreased 
in size to 4 cm at 3 months and was 3.3 cm at 8 months on duplex examination. By I year 
a spiral computed tomographic study confirmed complete regression of  the aneurysm, 
with mild shortening and angulation of the tmsupported body of the aortoiliac endolu- 
minal prosthesis. The case demonstrates a potential of  endograft reatment of  aortic 
aneurysms and describes the changes in prosthesis configuration and position that 
occurred after implantation. (J Vase Surg 1997;26:133-7.) 
Endovascular prostheses are being evaluated exten- 
sively for their use in the treatment o f  arterial aneu- 
rysms, arteriovenous fistulae, and vascular occlusive 
disease. >7 Promising clinical studies have docu- 
mented the utility o f  these methods, and the future 
of  this technology will rely on improvements made in 
devices and evaluation of  the long-term healing 
when implanted to treat various pathologic entities. 
This paper describes resolution of  an abdominal aor- 
tic aneurysm after endograft exclusion by an aor- 
toiliac endograft, contralateral iliac artery occlusion, 
and femorofemoral bypass grafting to restore blood 
flow to the contralateral limb. This technique for 
treating abdominal aortic aneurysms has been de- 
scribed by several investigators as an acceptable 
method for excluding the aneurysm and revasculariz- 
ing the lower extremities when a bifurcated evice is 
not available, or when access to the lesion is limited 
to a single iliac artery. 1,3,s,7 
CASE REPORT 
The patient was a 71-year-old man who had a compli- 
cated medical history, which included coronary artery dis- 
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ease, renal failure on dialysis, prostate cancer treated with 
radiation therapy, and a recent history of diverticulitis that 
resolved with nonsurgical treatment. Approximately 1
month before admission, the patient was seen with com- 
plaints of significant epigastric discomfort and heme-posi- 
rive stools. At that time he was found to have peptic ulcer 
disease, probably related to chronic aspirin use. A com- 
puted tomographic (CT) scan of his abdomen during his 
evaluation demonstrated a 6.5 cm abdominal aortic aneu- 
rysm. 
A preintmwention a giogram and shaded surface-ren- 
dered spiral CT scan (Picker PQ-2000 Spiral Scanner, 
voxel work station, and software; Picker International, 
Cleveland, Ohio) confirmed that the patient's abdominal 
aortic aneurysm had morphologic characteristics that were 
compatible with endoluminai repair. The infi'arenal aneu- 
rysm neck was of adequate length and diameter, and ap- 
propriate device fixation sites were present in the iliac 
arteries. There was no distal neck, which precluded the use 
of an aorto/aortic tube graft. Because of the patient's 
medical condition and the favorable anatomy of the aneu- 
rysm, the patient was offered and opted to be treated by an 
endoluminal bypass graft. The patient was entered into an 
investigator-sponsored Investigational Device Exemption 
approved by the Food and Drug Administration for evalu- 
ation of endovascular p ostheses to treat vascular lesions. 
He consented for the procedure using both a conventional 
operative consent form and a consent for the endoluminal 
graft study approved by the Institutional Review Board. 
The patient was prepped and draped on a carbon fiber 
interventional table in the endovascular suite in a manner 
identical to preparation for conventional surgical repair. 
After induction of general anesthesia, Swan-Ganz and ra- 
dial artery catheters were inserted. The procedure was 
begun by making bilateral groin incisions, with exposure of 
the femoral arteries. The dissection of the right groin was 
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extended beneath the inguinal ligament o expose and 
mobilize this artery to facilitate passage of the endoluminal 
delivery system. The right external i iac artery was adherent 
to and encased by fibrotic tissue in the retroperitoneum 
related to previous radiation therapy. After dissection of 
the artery and mobilization to the level of the common iliac 
artery, the vessel was then cannulated through a small stab 
incision in the common femoral artery. A 0.02S-inch Plat- 
inum Plus guidewire (Meditech, Inc., Natick, Mass.) was 
inserted through the angiographic catheter, the catheter 
was removed, and a 3.5F monorail, 20 MHz intravascular 
ultrasound (IVUS) catheter (Meditech) was passed over 
the wire to interrogate the length of the abdominal aorta 
and right iliac artery segments. The location and dimen- 
sions of the infrarenal neck were identified. The infrarenal 
aortic neck as measured by concentric IVUS images was 22 
mm in diameter compared with 24 mm measured from the 
axial images on the preintervention CT scan. The length of 
the infrarenal neck was appropriately 2.5 to 3.0 cm. 
The estimated length of the distance from the infrare- 
nal neck to an appropriate distal fixation site in the right 
common iliac artery just proximal to the hypogasttic artery, 
as determined by a computer-generated measurement on 
the spiral CT scan, was 16.5 cm. A comparable measure- 
ment was made using 1VUS by withdrawing the catheter 
from a point directly below the lowest-lying renal orifice to 
the origin of the hypogastric artery. With this method, this 
distance was measured at 16 cm, with diameters measured 
at 13 mm and 10 mm in the common and external iliac 
arteries, respectively. The diameter of the same sites in the 
iliac arteries were measured at 16 mm and 12 mm on the 
axial CT images before intervention. 
Because of the lack of a distal neck and the unavailabil- 
ity of a bifurcated prosthesis, an aorta-right iliac artery 
interposition endoluminal device was fabricated by secur- 
ing an extra-large Palmaz balloon-expandable st nt (John- 
son & Johnson Interventional, Inc., Warren, N.J.) to the 
aortic end of a tapered 24 X 12 Cooley Vetisoft bifurcated 
vascular prosthesis (Meadox Medicals, Inc., Oakland, 
N.J.). One iliac limb of the prosthesis was removed and 
oversewn to produce the aortoiliac onfiguration. A 16 cm 
length device was deployed with a 24 mm × 8 cm Triax 
extrusion balloon (Meditech) for expansion of the proxi- 
mal stent using methods that have been previously de- 
scribed. 7 After deployment of the proximal stent he deliv- 
ery sheath was then retracted to a level just beneath the 
distal end of the prosthesis. This end of the graft was 
secured by deploying a P308 Palmaz stent crimped onto a 
12 mm diameter angioplasty balloon. The stent was de- 
ployed so that the middle of the stent overlapped the distal 
end of the prosthesis by 1 cm, thus making the total length 
of the device 17 cm. After deployment an aortogram was 
obtained to inspect the proximal deployment site, the 
length of the graft, and the distal stent positioning. The 
endoprosthesis appeared to be fully expanded, and there 
was no evidence of an anastomotic leak or graft deformity. 
The catheter was then exchanged for a 0.025-inch diame- 
ter metal guidewire, and a 3.5F 20 MHz IVUS probe was 
then passed along the length of the wire to inspect he 
continuity of the endoluminal prosthesis. The proximal 
deployment site was confirmed to be directly beneath the 
renal vein at its chosen location with full deployment of the 
stent to the aortic wall. There was excellent conformity of 
the vascular prosthesis throughout its length except for 
some minor irregularities at the point where the iliac limb 
passed from the aorta into the right iliac artery. The distal 
fixation site with the stent device demonstrated full deploy- 
ment with no evidence ofperigraft leak. 
The introducer sheath and guidewires were then re- 
moved, and an endarterectomy was performed on the tight 
common femoral artery after extending a small opening 
that had been made to pass the introducer sheath and to 
form a site in the right femoral artery for a femorofemoral 
bypass procedure. 
The left groin was also simultaneously prepped for 
femorofemoral bypass grafting by performing an arteriot- 
omy. Before securing the left limb of the femorofemoral 
bypass graft, the left common iliac artery was occluded near 
the bifurcation by passing a5 cm length of Cooley Vetisoft 
vascular prosthesis that had been secured to a P308 Palmaz 
stent with the most proximal end of the graft ligated so 
that after deployment of the stent he iliac artery would be 
occluded. This was performed without complications, and 
a follow-up angiogram confirmed occlusion of the vessel 
and filling of collateral vessels. The femorofemoral bypass 
procedure was then completed using a ring-reinforced 10 
mm internal diameter polytetrafluoroethylene graft (Im- 
pra, Inc., Tempe, Ariz.). After completion of this proce- 
dure, there was excellent flow through all components of 
the reconstruction, with audible signals on Doppler exam- 
ination. 
After the procedure the patient was returned to the 
intensive care unit, where he was monitored for 1 day. He 
was then transferred to the surgical ward, where he recov- 
ered full ambulatory and gastrointestinal function within 
48 hours after the procedure. Before discharge on day 4, 
the patient underwent a spiral CT scan, which confirmed 
complete xclusion of the abdominal aortic aneurysm by 
the endoluminal prosthesis, with rapid flow through the 
aortoiliac device and femorofemoral reconstruction. The 
internal diameter of the proximal and distal fixation sites 
within the stents was 24 and 12 mm, respectively, with the 
cephalad end of the proximal ,stent being at the top of the 
L 2 vertebral body. The length of the endograft was mea- 
sured as 20.0 cm using the calibrated measurements in the 
shaded surface-rendered CT reconstruction software. 
At subsequent follow-up examinations, the patient re- 
mained fully active, with improvement in his preinterven- 
tional status and some relief of the claudication that he 
reported before the procedure. The patient's ankle-bra- 
chial indexes at all intervals remained at 0.7 bilaterally and 
were unchanged from his preintervention status. At the 
3-month follow-up, a Duplex examination demonstrated 
that the maximum diameter of the aneurysm had decreased 
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to 4 cm fi'om 6.5 cm before the intervention. By 8 months 
after intervention, a duplex evaluation confirmed that the 
aneurysm had decreased to 3.3 cm diameter, with near 
complete regression of the aneurysm. This observation was 
confirmed on a spiral CT scan that was obtained at 1 year 
follow-up. This examination revealed that the abdominal 
aortic aneurysm had completely regressed, with mild short- 
ening and angulation of the aortoiliac prosthesis to accom- 
modate the healing reaction (Fig. 1). The diameter of the 
proximal and distal stent fixation sites were 24 mm and 12 
mm, being unchanged from the time of the procedure. 
The length of the device was 18.1 cm, with the cephalad 
end of the proximal stent now being at the top of the L 3 
vertebral body, with the distance from the superior mesen- 
teric artery to the top of the stent being 4 cm compared 
with 1 cm at the time of device development. The position 
of the iliac stents was unchanged. The diameter of the 
aortic body of the prosthesis was 24 ram, with the outside 
diameter of the collapsed aneurysm being 30 mm. 
DISCUSSION 
This patient's clinical course after endoluminal graft 
exclusion of  his abdominal aortic aneurysm presents 
several interesting observations that have an impact 
on the potential utility of  this technology. The first 
important observation is that the diameter o f  the 
abdominal aortic aneurysm rapidly decreased from 
6.5 cm to near complete resolution by 8 months. 
Regression in AAA diameter appears to correlate 
with exclusion of  the aneurysm. 8 Although complete 
regression of  an AAA after endograft deployment has 
been postulated as a potential by several investiga- 
tors, there are no published reports that document 
this phenomenon.  Additional investigators are evalu- 
ating volume measurement o f  the anemTsm after 
intervention as an alternative, and possible a more 
sensitive, indicator of  regression. 9 
There are several potential reasons for regression 
in this patient. One is that the aneuwsm contained 
limited thrombus, with only mild calcification of  the 
wall as seen on the preintmwention CT scan. I f  these 




Fig. 1. Spiral and axial CT images of aneurysm acquired 
from the same level in aortoiliac vessels before interven- 
tion, 4 days after intervention, and 1 year after the proce- 
dure. Note location of superior mesenteric artery (short 
arrow) compared with cephalad end of proximal stent 
(long arrow) in 4-day and 1-year econstructions. In some 
areas, false appearance of mild residual dilation of aortic 
and iliac segments i a result of calcification in the wall of 
vessels being indistinguishable from contrast within the 
arterial umen on the shaded surface-rendered reconstruc- 
tions. 
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aneurysm regression after endograft exclusion, 
choosing aneurysms at a stage in their evolution 
where these characteristics predominate might lead 
to a higher egression rate. 
A second important observation is that the con- 
figuration of the unsupported portion of the aor- 
toiliac prosthesis had changed as the aneurysm re- 
gressed, and the positioning of the proximal end of 
the device had changed with caudal displacement of
the proximal stent. During the interval from the 
procedure to the 1-year follow-up examination, a 
gentle curve in the aortoiliac limb at the time of 
deployment had formed a nearly 90-degree angle by 
1 year. This angulation is most likely related to some 
degree of shortening as the aneurysm regressed and 
to perivascular fibrous capsule formation. The short- 
ening was confirmed by the decrease in length of the 
device (20.0 and 18.1 cm) as measured from the 
spiral CT reconstructions. Mthough no apparent 
hemodynamic effect has resulted--the patient's 
ankle-brachial indexes and ambulatory status are 
unchanged--monitoring of the conformity of the 
device will be required to assure that more severe 
angulation and narrowing does not occur. This 
observation also has relevance to the construction 
of endoluminal prostheses, particularly when un- 
supported limbs of a fabric device are deployed in 
lesions that may change configuration over time. 
Devices with stent support along their entire 
length may offer a protection from the angulation 
or narrowing that may occur in this situation. It 
may also be that stent support may lead to more 
severe narrowing or cause stent fracture if severe 
angulation develops. The implications of this find- 
ing and possible remedies are yet to be deter- 
mined. 
A discrepancy between the preintervention aortic 
neck and iliac artery dimensions as measured by axial 
CT and IVUS highlight another important aspect of 
evolving endograft technologies. We frequently find 
differences in the diameters obtained from CT im- 
ages and IVUS interrogations and have relied on the 
IVUS as the most accurate method to size devices. 7 
This observation does not detract from the impor- 
tance of axial and spiral CT scans for determining 
aortic dimensions and morphologic haracteristics 
before and after intervention, for determining pa- 
tient candidacy for procedures, and for evaluating 
long-term function of the device. We also have no 
explanation for the difference in the length of the 
device (20.0 cm) measured on day 4 compared with 
the known length of 17 cm at the time of implanta- 
tion. Slight elongation might have occurred after 
implantation, although crimps in the Vcrisoft pros- 
thesis were removed before implantation by heat 
pressing and by elongation to the maximal length 
when the device was packed into the delivery cathe- 
ter. Our current approach isto use a combination of 
axial and spiral CT imagcs and IVUS measurements 
to assure successful deployment while realizing that 
both of these methods have limitations, with the 
eventual role of each to be determined asthe tech- 
nologies evolve. 
Preliminary reports that describe the healing of 
endoluminal prosthesis are limited, although studies 
are beginning to appear that suggest that tissue in- 
corporation and sealing occur rapidly where there is 
direct device-to-vessel contact. 10-12 The potential for 
regression of aneurysms would obviously offer a new 
perspective for a long-term durability and healing, 
particularly if the aneurysm cavity regresses and is 
replaced by viable tissue. The potential for aneurysm 
remodeling and lesion regression is a promising find- 
ing in this patient; the frequency of this occurrence 
and the variables that led to this phenomenon have 
yet to be determined. 
The implications of the caudal migration of the 
proximal aortic stent have yet to be determined. The 
preliminary healing studies in both animals ~3,14 and 
human beings 1,7,12 that evaluated the type of device 
used in this patient have noted rapid incorporation of
the open-ended stent structure on the proximal end 
of the device. Appropriate sizing has led not only to 
the prevention of endoleaks but also promoted heal- 
ing without migration. Further investigations are re- 
quired to elucidate the dynamics of the endograft/ 
aneurysm orphologic characteristics during regres- 
sion and to define the impact of the interactions of 
ultimate device confguration. 
A recent study by May et al.8 reports progressive 
decrease in the diameter of abdominal aortic aneu- 
rysms in 39 patients where complete sealing of the 
aneurysm has been maintained. They noted serial 
regression at 6-month, 12-month, and 18-month 
follow-ups of an average of 0.44 cm, 0.80 cm, and 
1.15 cm, but they did not discuss complete aneurysm 
regression. These data suggest that continued regres- 
sion at a predictable rate may occur and emphasizes 
the importance of serial observation todocument the 
effect of the healing on device configuration and 
patency. In that study, the authors noted acute en- 
largement of the aortic fixation sites, which stabilized 
over time. In the patient evaluated in this paper, no 
change in diameter was noted up to 1 year in either 
the aortic or iliac stent. We believe that IVUS sizing 
of fixation site might impact he enlargement with 
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t ime but  have not  acqui red sufficient data to evaluate 
this phenomenon.  
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